|
Canergy
|
100 mg
|
V/DCP/15/0040
|
Le Vet Beheer B.V., Nīderlande
|
QC04AD90
|
dogs
|
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Propentofylline
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande;Artesan Pharma, Vācija;GENERA Inc., Horvātija
|
| Date of authorisation/renewal: |
28-Apr-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 190224LI (20-Feb-2024)
|
| Labelling text: |
[DOCX] 050121M (14-Jan-2021)
|
| Summary of product characteristics: |
[DOCX] 280915ZA (28-Apr-2020)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/15/0040-01 |
100 mg |
1 |
PA/Al/PVH//Al blisteris, 10 tablete |
-
|
| V/DCP/15/0040-02 |
100 mg |
2 |
PA/Al/PVH//Al blisteris, 10 tablete |
-
|
| V/DCP/15/0040-03 |
100 mg |
3 |
PA/Al/PVH//Al blisteris, 10 tablete |
-
|
| V/DCP/15/0040-04 |
100 mg |
4 |
PA/Al/PVH//Al blisteris, 10 tablete |
-
|
| V/DCP/15/0040-05 |
100 mg |
5 |
PA/Al/PVH//Al blisteris, 10 tablete |
-
|
| V/DCP/15/0040-06 |
100 mg |
6 |
PA/Al/PVH//Al blisteris, 10 tablete |
-
|
| V/DCP/15/0040-07 |
100 mg |
7 |
PA/Al/PVH//Al blisteris, 10 tablete |
-
|
| V/DCP/15/0040-08 |
100 mg |
8 |
PA/Al/PVH//Al blisteris, 10 tablete |
-
|
| V/DCP/15/0040-09 |
100 mg |
9 |
PA/Al/PVH//Al blisteris, 10 tablete |
-
|
| V/DCP/15/0040-10 |
100 mg |
10 |
PA/Al/PVH//Al blisteris, 10 tablete |
-
|
| V/DCP/15/0040-11 |
100 mg |
25 |
PA/Al/PVH//Al blisteris, 10 tablete |
-
|
| V/DCP/15/0040-12 |
100 mg |
50 |
PA/Al/PVH//Al blisteris, 10 tablete |
-
|
|